[Efficiacy of combined eglonil and avestin administration for pharmacocorrection of depressive disorders in women with hypoestrogenic syndrome].
The aim of the present study was to investigate the efficacy of combined administration of with eglonil and ovestin in low doses for the pharmacocorrection of depressive disorders in women after total ovariectomy. The results obtained showed evidence for a marked efficacy of the combined therapy with eglonil and ovestin in low doses as compared to the standard hormonal replacement therapy in women with hypoestrogenic syndrome. This is confirmed by a significant decrease of anxiety and depression on the common clinical scale and in neuropsychological tests.
Sapronov
N S
NS
Fedotova
Iu O
IuO
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D004964:Estriol / Q000008:administration & dosage*; D004967:Estrogens; D005260:Female; D006801:Humans; D008875:Middle Aged; D010052:Ovariectomy; D013469:Sulpiride / Q000008:administration & dosage*; D013577:Syndrome
D018687:Antidepressive Agents, Second-Generation; D004967:Estrogens; D013469:Sulpiride; D004964:Estriol